On Rare Disease Day 2026, Certara experts share how cross-functional innovation, regulatory strategies for rare…
Certara2026 年 2 月 26 日
Opinion: To Accelerate Rare Disease Progress, Take a Sandbox Approach
Explore how a collaborative “sandbox” approach—combining flexible regulation, data modeling, and stakeholder engagement—can transform rare…
Certara2026 年 1 月 30 日
Certara’s Virtual Twin® QSP Models: Transforming Rare Disease Research into Clinical Insights
Certara’s Virtual Twin® QSP Models are transforming rare disease drug development, with real-world insights from…
Certara2025 年 11 月 25 日
Exposure–Response Analysis of Donidalorsen for the Treatment of Hereditary Angioedema
Certara and Ionis analyzed Phase 3 OASIS-HAE data showing flexible, effective donidalorsen dosing can reduce…
Certara2025 年 11 月 12 日
Supporting Ionis’ Donidalorsen BLA with Biomarker HAE Attack Rate Modeling
Discover how Certara applied exposure-response analysis and advanced modeling to optimize Donidalorsen dosing for hereditary…
Certara2025 年 11 月 10 日
Move Away From Animal-Only Testing May Improve, Speed Rare Disease Research
The article, "Move Away From Animal-Only Testing May Improve, Speed Rare Disease Research," explores a…
Danielle Pillsbury2025 年 9 月 10 日
Optimizing Dosing and Regulatory Outcomes in Duchenne Muscular Dystrophy (DMD) Drug Development
Certara supported DMD drug development for Givinostat, helping Italfarmaco with pharmacometric and regulatory strategy.
Certara2025 年 7 月 29 日
Digital twins and virtual trials: A new era in rare disease drug development
Discover how using digital twins in rare disease drug development is improving precision and accelerating…
Certara2025 年 7 月 22 日
Rare Oncology Product Launch Playbook: Universal Strategies for Success in the U.S. and Europe
Lorem ipsum dolor sit amet consectetur. At venenatis urna sapien ut lorem enim. Morbi lectus…
Certara2025 年 2 月 28 日
Accelerating CMC Success in Rare Disease Drug Development
New drug approvals in rare diseases are rising, bringing hope to patients. But with accelerated…
Certara2025 年 2 月 26 日
